Incidental Gallbladder Carcinoma Discovered during Living Liver Donor Evaluation

在活体肝脏捐献者评估过程中意外发现胆囊癌

阅读:1

Abstract

INTRODUCTION: Gallbladder cancer (GBC) is the most common and aggressive malignancy of the biliary tract, often diagnosed at an advanced stage with a poor prognosis due to its typically insidious onset and nonspecific symptoms. Early-stage GBC is usually asymptomatic and most frequently discovered incidentally following cholecystectomy for presumed benign disease. This case report details the rare incidental discovery of GBC in a potential living liver donor, an individual significantly younger than the typical demographic for this cancer, highlighting the value of comprehensive donor screening protocols. CASE PRESENTATION: A 45-year-old asymptomatic Arab female with no significant medical history was evaluated as a potential living liver donor for her brother. Routine preoperative imaging revealed marked gallbladder wall thickening, a solitary gallstone larger than 3 cm, and a suspicious mass extending into the liver. A subsequent PET/CT scan confirmed an FDG-avid lesion localized to the gallbladder and adjacent liver, with no evidence of distant metastasis. The patient underwent an open en bloc resection of the gallbladder with hepatic segments IVb and V. Histopathological examination confirmed a moderately differentiated adenocarcinoma (pT2bN1M0, stage IIIB). The patient recovered well postoperatively and completed six cycles of adjuvant chemotherapy. At a 3-year follow-up, she remains asymptomatic with no evidence of disease recurrence. CONCLUSION: This case represents a unique and valuable contribution to the medical literature, documenting a rare incidental finding of gallbladder carcinoma in an asymptomatic living liver donor candidate. The rigorous screening protocols standard for living organ donation proved to be lifesaving by uncovering an occult malignancy at a treatable stage. This report underscores the importance of maintaining a high index of suspicion for any gallbladder abnormalities detected during donor evaluation and serves as a critical reference for transplant, surgical, and oncology teams.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。